Polymer, Journal Year: 2024, Volume and Issue: 316, P. 127788 - 127788
Published: Nov. 16, 2024
Language: Английский
Polymer, Journal Year: 2024, Volume and Issue: 316, P. 127788 - 127788
Published: Nov. 16, 2024
Language: Английский
Trends in Food Science & Technology, Journal Year: 2024, Volume and Issue: 147, P. 104473 - 104473
Published: March 29, 2024
Language: Английский
Citations
5Food Chemistry, Journal Year: 2025, Volume and Issue: 471, P. 142841 - 142841
Published: Jan. 9, 2025
Language: Английский
Citations
0Drug Delivery and Translational Research, Journal Year: 2025, Volume and Issue: unknown
Published: March 20, 2025
Language: Английский
Citations
0Advanced Functional Materials, Journal Year: 2025, Volume and Issue: unknown
Published: April 11, 2025
Abstract Intraoral delivery of active pharmaceutical ingredients (API) is an attractive approach to improve their local therapeutic efficacy or enable systemic delivery. It offers several advantages, such as high drug concentration at the intraoral target site and rapid access circulation due vascularization oral cavity, bypassing first‐pass metabolism. However, limitations need be addressed, relatively short residence time formulations applied in cavity salivation, swallowing reflex, tongue movement, well poor membrane permeability of, particular, hydrophilic drugs. Within this review, a comprehensive summary latest strategies formulation approaches field provided, focusing on those pursued by academia industry overcome challenges. An overview provided excipients that are generally recognized safe (GRAS) utilized enhance systems, mucoadhesive materials, enzyme inhibitors, permeation enhancers. Innovative dosage forms outlined, covering solid, semi‐solid, liquid systems aerosols. Future trends, including self‐emulsifying microneedles, situ bioprinting, explored, presenting new opportunities for
Language: Английский
Citations
0International Journal of Pharmaceutics, Journal Year: 2025, Volume and Issue: unknown, P. 125711 - 125711
Published: May 1, 2025
Language: Английский
Citations
0Pharmaceutics, Journal Year: 2025, Volume and Issue: 17(5), P. 572 - 572
Published: April 26, 2025
Background/Objectives: The ineffective delivery of drugs into tumors and the existence multidrug resistance (MDR) are primary causes chemotherapy failure. Downregulation Sonic Hedgehog (Shh) pathway has been shown to reduce P-glycoprotein (P-gp) expression on cell membranes resist MDR. Methods: In this study, we combine cyclopamine (CYP, a potent Shh antagonist) with paclitaxel (PTX, an antitumor drug that can produce MDR) in nano-drug system (CYP NP PTX NP) for treatment drug-resistant breast cancer. Nanoparticles were characterized size, zeta potential, encapsulation efficiency. P-gp expression, nanoparticle accumulation, cytotoxicity, apoptosis evaluated MCF-7 MCF-7/Adr cells. Penetration ability was assessed using 3D multicellular tumor spheroids. Antitumor efficacy biodistribution validated MCF-7/Adr-bearing nude mice models. Results: Our engineered CYP nanoparticles (~200 nm) demonstrated prolonged intratumoral retention, enabling sustained inhibition functional suppression. This size-optimized formulation created favorable microenvironment smaller (~30 nm), facilitating deeper penetration enhanced cellular uptake. Meanwhile, by down-regulating NPs could convert cells PTX-sensitive both cytotoxicity induction through pathway. combination augmented effects Conclusions: offers new therapeutic strategy cancer treatment.
Language: Английский
Citations
0Designed Monomers & Polymers, Journal Year: 2024, Volume and Issue: 27(1), P. 21 - 34
Published: May 30, 2024
In this paper, a novel mono-methacrylated β-cyclodextrin (β-CD) monomer mediated by disulfide bond was synthesized, and then thermal copolymerized with HEMA in the presence of little crosslinker to prepare redox-responsive hydrogel for regulated drug delivery. The structure confirmed FTIR,
Language: Английский
Citations
2Frontiers in Cardiovascular Medicine, Journal Year: 2024, Volume and Issue: 11
Published: July 2, 2024
Introduction The incidence of metabolic disorders during pregnancy is increasing year by year, with diseases including hypertension and hyperlipidemia. Statins are the primary drugs for treating hyperlipidemia or atherosclerosis, yet some patients remain unresponsive to them, pregnant women prohibited from taking statins. Curculigoside major biologically active natural product present in Curculigo orchioides . Methods In this study, A high-fat mice model was developed study lipid-lowering effect curculigoside. Using intestinal Caco-2 cell monolayer, curculigoside transport properties at two temperatures possible transporters were systemically studied. Results concentrations used experiments have no toxic cells. transfer apical basolateral side strongly influenced temperature. P-glycoprotein, breast cancer resistance protein, efflux crucial components human line Caco-2. can significantly affect contents total cholesterol, triglycerides, high-density lipoprotein low-density cholesterol mice. Discussion potential mechanism offer valuable insights design development hypolipidemic like anti-atherosclerotic also be helpful further pharmacological activity
Language: Английский
Citations
1Emergent Materials, Journal Year: 2024, Volume and Issue: unknown
Published: Sept. 4, 2024
Language: Английский
Citations
1Polymer, Journal Year: 2024, Volume and Issue: 316, P. 127788 - 127788
Published: Nov. 16, 2024
Language: Английский
Citations
0